Tickerplace logo

Tickerplace

4D Molecular Therapeutics, Inc. logo

FDMT4D Molecular Therapeutics, Inc.

FDMT Stock Price, Valuation & Chart | 4D Molecular Therapeutics, Inc.

Compare
$14.940+0.59 (+4.11%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyFDMT intrinsic valueFDMT calculated fair value vs price
OverviewFinancialsDividendsRatios

FDMT Historical price chart

FDMT Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization781.01M
PE Ratio-5.81
EPS-2.57
Trading Volume1.04M
Today's High/Low15.12/14.08
Dividend Yield0.00
52 Week High/Low16.93/6.09
Shares Outstanding52.28M
FDMT Financial Statement
FDMT Analyst ratings
FDMT Analysis & performance metrics

FDMT Company profile

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of…

FDMT Management team

Management
David H. Kirn M.D.CEO
Co-Founder, Chief Executive Officer & Director
Noriyuki Kasahara M.D., Ph.D.
Chief Scientific Officer
Theresa Janke
Co-Founder & Chief of Staff
Scott P. Bizily J.D., Ph.D.
Chief Legal Officer & Corporate Secretary
John F. Milligan Ph.D.
Executive Chairman
Fariborz Kamal Ph.D.COO
President & Chief Operating Officer
Uneek MehraCFO
Chief Financial & Business Officer
Alan H. Cohen FAAAAI, FAAP, FACAAI, FCCP, M.D.
Senior Vice President & Therapeutic Area Head of Pulmonology
Total 8 executives

FDMT Frequently asked questions

What is 4D Molecular Therapeutics, Inc. (FDMT) Stock Price?

Current stock price of 4D Molecular Therapeutics, Inc. (FDMT) stock is $14.940. The stock price is +4.11% higher in the session. The intraday range can be seen from this page. Volume of 4D Molecular Therapeutics, Inc. (FDMT) stock is 1.04M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the 4D Molecular Therapeutics, Inc. (FDMT) stock price going up or down today?

The stock price of 4D Molecular Therapeutics, Inc. (FDMT) can change with earnings, company news, and overall market sentiment. 4D Molecular Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the 4D Molecular Therapeutics, Inc. stock expensive at its current price?

Whether 4D Molecular Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for FDMT on this page is -5.81. EPS on this page is -2.57. Compare those figures with peers and growth expectations before deciding if the current 4D Molecular Therapeutics, Inc. price is justified.

How has the stock price of 4D Molecular Therapeutics, Inc. (FDMT) performed historically?

Historical performance for 4D Molecular Therapeutics, Inc. (FDMT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how FDMT reacted to past earnings and market events.

Should I buy 4D Molecular Therapeutics, Inc. (FDMT) stock, at this price?

Buying 4D Molecular Therapeutics, Inc. (FDMT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.